In one of the recent studies, Luteolin was shown to inhibit the Akt/osteopontin (OPN) pathway, which resulted in the promotion of caspase-dependent apoptosis in SK-Hep-2 human hepatocellular carcinoma cells [107]. The gene discussed is SPP1; the disease is hepatocellular carcinoma.